检验医学
檢驗醫學
검험의학
LABORATORY MEDICINE
2014年
4期
375-379
,共5页
蒯守刚%王卫萍%裴豪%范明%刘君%周希科%尚忠波%邵海枫
蒯守剛%王衛萍%裴豪%範明%劉君%週希科%尚忠波%邵海楓
괴수강%왕위평%배호%범명%류군%주희과%상충파%소해풍
产气肠杆菌%碳青霉烯类%质粒%β-内酰胺酶%肠杆菌科
產氣腸桿菌%碳青黴烯類%質粒%β-內酰胺酶%腸桿菌科
산기장간균%탄청매희류%질립%β-내선알매%장간균과
Enterobacter aerogen%Carbapenem%Plasmid%Beta-lactamase%Enterobacteriaceae
目的研究一株临床分离的碳青霉烯类药物耐药产气肠杆菌的耐药机制和耐药基因传播机制。方法采用琼脂稀释法检测菌株对抗菌药物的最低抑菌浓度(MIC),采用质粒接合试验、质粒提取、DNA分子杂交、等电聚焦电泳(IEF)、聚合酶链反应(PCR)、DNA测序和外膜蛋白分析研究菌株的耐药基因及其传递机制。结果IEF显示临床分离的产气肠杆菌株含有3条β内酰胺酶条带,等电点(pI)分别为5.4、6.7和7.8。PCR扩增及测序结果表明它们分别为TEM1(pI5.4)、KPC2(pI6.7)、DHA1(pI7.8)β内酰胺酶。接合菌含有2条β内酰胺酶条带,pI为6.7和7.8。接合试验、质粒提取和分子杂交试验结果显示KPC2和DHA1基因定位于同一个约56kb大小的质粒上。与临床野生产气肠杆菌株相比,外膜蛋白电泳分析显示耐药分离株缺失41000外膜蛋白。结论产气肠杆菌分离株对碳青霉烯类抗菌药物耐药可能由A类2f组KPC2酶介导,DHA1酶合并外膜蛋白缺失也可能与碳青霉烯类药物耐药机制形成有关。
目的研究一株臨床分離的碳青黴烯類藥物耐藥產氣腸桿菌的耐藥機製和耐藥基因傳播機製。方法採用瓊脂稀釋法檢測菌株對抗菌藥物的最低抑菌濃度(MIC),採用質粒接閤試驗、質粒提取、DNA分子雜交、等電聚焦電泳(IEF)、聚閤酶鏈反應(PCR)、DNA測序和外膜蛋白分析研究菌株的耐藥基因及其傳遞機製。結果IEF顯示臨床分離的產氣腸桿菌株含有3條β內酰胺酶條帶,等電點(pI)分彆為5.4、6.7和7.8。PCR擴增及測序結果錶明它們分彆為TEM1(pI5.4)、KPC2(pI6.7)、DHA1(pI7.8)β內酰胺酶。接閤菌含有2條β內酰胺酶條帶,pI為6.7和7.8。接閤試驗、質粒提取和分子雜交試驗結果顯示KPC2和DHA1基因定位于同一箇約56kb大小的質粒上。與臨床野生產氣腸桿菌株相比,外膜蛋白電泳分析顯示耐藥分離株缺失41000外膜蛋白。結論產氣腸桿菌分離株對碳青黴烯類抗菌藥物耐藥可能由A類2f組KPC2酶介導,DHA1酶閤併外膜蛋白缺失也可能與碳青黴烯類藥物耐藥機製形成有關。
목적연구일주림상분리적탄청매희류약물내약산기장간균적내약궤제화내약기인전파궤제。방법채용경지희석법검측균주대항균약물적최저억균농도(MIC),채용질립접합시험、질립제취、DNA분자잡교、등전취초전영(IEF)、취합매련반응(PCR)、DNA측서화외막단백분석연구균주적내약기인급기전체궤제。결과IEF현시림상분리적산기장간균주함유3조β내선알매조대,등전점(pI)분별위5.4、6.7화7.8。PCR확증급측서결과표명타문분별위TEM1(pI5.4)、KPC2(pI6.7)、DHA1(pI7.8)β내선알매。접합균함유2조β내선알매조대,pI위6.7화7.8。접합시험、질립제취화분자잡교시험결과현시KPC2화DHA1기인정위우동일개약56kb대소적질립상。여림상야생산기장간균주상비,외막단백전영분석현시내약분리주결실41000외막단백。결론산기장간균분리주대탄청매희류항균약물내약가능유A류2f조KPC2매개도,DHA1매합병외막단백결실야가능여탄청매희류약물내약궤제형성유관。
Objective To investigate the resistance and transmission mechanisms of a clinical isolate of carbapenem-resistant Enterobacter aerogen.Methods The minimal inhibition concentrations (MIC)of antimicrobial agents were determined by agar dilution method,and plasmid conjugation experiment,plasmid extraction and DNA molecular hybridization, isoelectric focusing electrophoresis (IEF ), polymerase chain reaction (PCR ), DNA sequencing and outer-membrane protein analysis were used for analyzing the resistant gene and transmission mechanism. Results IEF showed that there were 3 bands of beta-lactamases with isoelectric point (pI)of 5.4,6.7 and 7.8 in the clinical isolate of carbapenem-resistant Enterobacter aerogen.These 3 bands of beta-lactamases were confirmed to be TEM-1 (pI 5.4),KPC-2(pI 6.7)and DHA-1 (pI 7.8)by PCR amplification and DNA sequencing,and 2 of them (pIs of 6.7 and 7.8)were found that they can be transferred by plasmid conjugantion experiment.KPC-2 and DHA-1 genes were located on an about 56 kb plasmid by plasmid conjugation experiment,plasmid extraction and DNA molecular hybridization.Outer-membrane protein electrophoresis analysis revealed that a 41 000 outer-membrane protein was absent in the clinical isolate of carbapenem-resistant Enterobacter aerogen comparing with clinical wild-type Enterobacter aerogen.Conclusions The clinical isolate of Enterobacter aerogen resistant to carbapenem produces a plasmid-mediaed carbapemase KPC-2 which belongs to Group 2f,Class A beta-lactamase.DHA-1 enzyme with outer-membrane protein absence may be related with the resistant mechanism of carbapenem-resistance in the isolate of Enterobacter aerogen.